Insulin Pork
drugOn this page
Also known as Insulin porcineInsulin porcine insulin
Summary
Insulin Pork (CHEMBL1201539) is an approved protein; indicated across 23 conditions including diabetes mellitus and coronary artery disorder.
At a glance
- Status: Approved (max clinical phase 4)
- Modality: Protein
- Indications: 23 conditions
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL1201539 |
| Name | Insulin Pork |
| Type | Protein |
| Max phase | 4 |
Also known as: Insulin porcine, Insulin porcine insulin, Insulin pork, INSULIN PORK
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
23 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).
| Indication | Trial phase | MONDO | EFO |
|---|---|---|---|
| diabetes mellitus | 3 | MONDO:0005015 | EFO:0000400 |
| coronary artery disorder | 3 | MONDO:0005010 | EFO:0001645 |
| type 1 diabetes mellitus | 3 | MONDO:0005147 | MONDO:0005147 |
| type 2 diabetes mellitus | 3 | MONDO:0005148 | MONDO:0005148 |
| gestational diabetes | 3 | MONDO:0005406 | EFO:0004593 |
| hyperglycemia | 3 | MONDO:0002909 | HP:0003074 |
| bone fracture | 2 | MONDO:0005315 | EFO:0003931 |
| Parkinson disease | 2 | MONDO:0005180 | MONDO:0005180 |
| hyperlipidemia | 2 | MONDO:0021187 | MONDO:0021187 |
| injury | 1 | MONDO:0021178 | EFO:0000546 |
| obesity disorder | 1 | MONDO:0011122 | EFO:0001073 |
| chronic progressive multiple sclerosis | 1 | MONDO:0005284 | EFO:0003840 |
| relapsing-remitting multiple sclerosis | 1 | MONDO:0005314 | EFO:0003929 |
| delirium | 1 | MONDO:0045057 | EFO:0009267 |
| hyperinsulinism | 1 | MONDO:0002177 | HP:0000842 |
| hypoglycemia | 1 | MONDO:0004946 | HP:0001943 |
| severe acute respiratory syndrome | 1 | MONDO:0005091 | MONDO:0100096 |
| carpal tunnel syndrome | 0 | MONDO:0007275 | EFO:0004143 |
5 further indication records had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.
Clinical trials
Total trials: 0.
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).